PDA

View Full Version : Data from Phase 3 clinical evaluation of Lymphoseek presented


News
12-13-2009, 11:02 PM
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that researchers who participated in the breast cancer arm of a Phase 3 clinical evaluation of Lymphoseek® presented data from their clinical experience at the International San Antonio Breast Cancer Symposium.

More... (http://www.news-medical.net/news/20091214/Data-from-Phase-3-clinical-evaluation-of-Lymphoseek-presented.aspx)